These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 7868484)

  • 1. Methotrexate in psoriatic arthritis.
    Singh YN; Verma KK; Kumar A; Malaviya AN
    J Assoc Physicians India; 1994 Nov; 42(11):860-2. PubMed ID: 7868484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriatic arthritis: clinical response and side effects to methotrexate therapy.
    Espinoza LR; Zakraoui L; Espinoza CG; Gutiérrez F; Jara LJ; Silveira LH; Cuéllar ML; Martínez-Osuna P
    J Rheumatol; 1992 Jun; 19(6):872-7. PubMed ID: 1404123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of psoriasis by methotrexate in the era of biotherapies: a study in 21 Tunisian patients].
    Khaled A; Ben Hamida M; Zeglaoui F; Kharfi M; Ezzine N; Fazaa B
    Therapie; 2012; 67(1):49-52. PubMed ID: 22487502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate in psoriatic polyarthritis.
    Pigatto PD; Gibelli E; Ranza R; Rossetti A
    Acta Derm Venereol Suppl (Stockh); 1994; 186():114-5. PubMed ID: 8073807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with long term low dose methotrexate treatment in rheumatoid arthritis and arthritic psoriasis].
    Náfrádi L; Varga L
    Orv Hetil; 1995 Jul; 136(29):1555-7. PubMed ID: 7637973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine consumption and methotrexate dosing requirement in psoriasis and psoriatic arthritis.
    Swanson DL; Barnes SA; Mengden Koon SJ; el-Azhary RA
    Int J Dermatol; 2007 Feb; 46(2):157-9. PubMed ID: 17269967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methotrexate--indications and adverse effects].
    Wolter M
    Hautarzt; 1991 Oct; 42(10):654. PubMed ID: 1757261
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and Efficacy of Methotrexate for Chinese Adults With Psoriasis With and Without Psoriatic Arthritis.
    Yan K; Zhang Y; Han L; Huang Q; Zhang Z; Fang X; Zheng Z; Yawalkar N; Chang Y; Zhang Q; Jin L; Qian D; Li X; Wu M; Xu Q; Zhang X; Xu J
    JAMA Dermatol; 2019 Mar; 155(3):327-334. PubMed ID: 30698628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous ulceration caused by methotrexate.
    Kazlow DW; Federgrun D; Kurtin S; Lebwohl MG
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl Case Reports):S197-8. PubMed ID: 12894123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate.
    Cheung KK; Chow KM; Szeto CC; Tai MH; Kwan BC; Li PK
    J Clin Rheumatol; 2009 Jun; 15(4):177-80. PubMed ID: 19502905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psoriatic arthritis: combined treatment with prospidin and methotrexate].
    Simonova OV; Nemtsov BF
    Ter Arkh; 2005; 77(8):60-4. PubMed ID: 16206608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate in psoriatic arthritis: a retrospective study.
    Kragballe K; Zachariae E; Zachariae H
    Acta Derm Venereol; 1983; 63(2):165-7. PubMed ID: 6189337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions.
    Kinder AJ; Hassell AB; Brand J; Brownfield A; Grove M; Shadforth MF
    Rheumatology (Oxford); 2005 Jan; 44(1):61-6. PubMed ID: 15611303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriatic onycho-pachydermo-periostitis successfully treated with low-dose methotrexate.
    Ochiai T; Washio H; Shiraiwa H; Takei M; Sawada S
    Med Sci Monit; 2006 Apr; 12(4):CS27-30. PubMed ID: 16572055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection.
    Rokhsar C; Rabhan N; Cohen SR
    J Am Acad Dermatol; 2006 Feb; 54(2):361-2. PubMed ID: 16443079
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate serum-level determinations during low-dose therapy of rheumatoid and psoriatic arthritis.
    Leeb B; Dunky A; Ogris E; Wohanka A; Schenk G; Gaismayer K; Eberl R
    Int J Clin Pharmacol Res; 1989; 9(3):209-15. PubMed ID: 2545638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.